Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Scientists track breast milk changes in 769 chinese moms

NCT ID NCT05235412

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study followed 769 healthy Chinese mothers and their babies for six months after birth. Researchers measured how breast milk composition (like protein, fat, and carbohydrates) changed over time and tracked infant growth. The goal was to better understand the link between maternal diet, milk content, and baby health outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

769 people

The number who actually took part.

Started

Nov 2021

Finished

Jul 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Generally healthy mothers with the intention to breastfeed, and their infants.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Mothers: 1. Generally healthy mothers with the intention to breastfeed. 2. Aged 18 years and above. 3. Written informed consent. Infants: 1. Generally healthy term born (gestational age between 37 and 42 weeks). 2. Breastfed by their mothers, either exclusively or in combination with infant milk formula, at enrolment. 3. Chinese ethnicity of mother and father. Exclusion Criteria: Mothers: 1. Participation in any other studies involving investigational or marketed products concomitantly or two weeks prior to entry into the study. 2. Difficulty to follow up and/or locate (e.g. known transfer to other hospitals, residing outside the city where the study site is located, or planning to move out of the current city; incapability of mothers to comply with study protocol or investigator' s uncertainty about the willingness or ability of the mothers to understand and comply with the protocol requirements. 3. Illegal drug use. 4. Regular smoking and/ or consumption of alcoholic beverages as per investigator's judgement. 5. A BMI of \<18.5 or ≥ 28 pre-pregnancy or during the first regular pregnancy check around or before 16 weeks of gestational age. 6. Acute infectious disease or neoplastic disease or any kind of weakening or debilitating conditions (with history of positive, hepatitis C virus (HCV) or HIV serological test at any time during the pregnancy). 7. Presence of mastitis, fungal infections of the nipple or areola; reactivation of herpes simplex (HSV) or varicella zoster infection in the mammary or thoracic region at the time of enrolment. 8. Presence of chronic diseases such as endocrine, cardiovascular, renal, respiratory or hepatic diseases. 9. Presence of psychosis and severe post-partum depression. 10. Presence of autoimmune disease such as systemic lupus erythematosus, systemic scleroderma, ulcerative colitis, Crohn's disease, celiac disease. 11. Women whose health condition, according to the investigator's judgement, could interfere with the study conduction and assessment. 12. Mothers who have given birth to twins or multiples or infant conceived with Assisted Reproductive Technology (ART). Infants: 1. Participation in any other studies involving investigational or marketed products concomitantly or two weeks prior to entry into the study. 2. At enrolment, any congenital abnormality, chromosomal disorder or severe disease which could interfere with the study conduct and assessment. 3. Consumption of food other than breast milk or infant formula. 4. Fully formula fed at enrolment.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast feeding are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Breast Feeding Breast Milk Expression

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Nanjing Medical University Jiangning Campus

    Nanjing, Jiangsu, 211166, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.